ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

VRDN Company Profile and Key Details

NASDAQ : VRDN

Viridian Therapeutics, Inc.

$15.94

0.06+0.38%

At Close 4:00 PM

$15.93

-0.01-0.06%

After-Market 03:59 PM

58.71

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

VRDN Stock Price Chart

Stock Price Today

Viridian Therapeutics, Inc. (VRDN) stock surged +0.38%, trading at $15.94 on NASDAQ, up from the previous close of $15.88. The stock opened at $15.80, fluctuating between $15.52 and $16.49 in the recent session.

Stock Snapshot

15.88

Prev. Close

15.8

Open

1.3B

Market Cap

81.49M

Number of Shares

15.52

Day Low

16.49

Day High

-5.19

P/E Ratio

89.93%

Free Float in %

-3.07

EPS (TTM)

8.9

Book Value

-3.73

Cash Flow per Share

969.32K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 07, 2025	15.80	16.50	15.52	15.94	989.88K
Mar 06, 2025	15.01	16.15	14.81	15.88	848.63K
Mar 05, 2025	15.28	15.58	15.10	15.28	821.92K
Mar 04, 2025	14.38	15.28	14.05	15.23	1.32M
Mar 03, 2025	15.60	15.70	14.10	14.41	1.22M
Feb 28, 2025	15.21	15.55	14.92	15.53	1.12M
Feb 27, 2025	15.45	15.90	15.26	15.29	783K
Feb 26, 2025	16.15	16.15	15.32	15.53	757.2K
Feb 25, 2025	15.91	16.11	15.45	15.54	1.16M
Feb 24, 2025	16.30	16.38	15.75	15.93	750.9K
Feb 21, 2025	16.81	16.97	16.25	16.27	878.3K
Feb 20, 2025	16.54	16.86	16.20	16.62	617.64K
Feb 19, 2025	15.70	16.65	15.62	16.58	917.56K
Feb 18, 2025	16.52	16.69	15.81	15.86	1.07M
Feb 14, 2025	17.07	17.25	16.38	16.40	1.03M
Feb 13, 2025	17.55	17.59	16.98	17.02	766.07K
Feb 12, 2025	17.43	17.76	16.68	17.47	1.17M
Feb 11, 2025	17.75	18.15	17.06	17.86	1.03M
Feb 10, 2025	17.96	18.08	17.53	18.00	473.93K
Feb 07, 2025	18.49	18.65	17.70	17.76	956.24K

Contact Details

Waltham, MA 02453

United States

Website: https://www.viridiantherapeutics.comContact: 617 272 4600

About Company

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was founded in 2006 and is headquartered in Waltham, Massachusetts.

Frequently Asked Questions

What is the current Viridian Therapeutics, Inc. (VRDN) stock price?

Viridian Therapeutics, Inc. (NASDAQ: VRDN) stock price is $15.94 in the last trading session. During the trading session, VRDN stock reached the peak price of $16.49 while $15.52 was the lowest point it dropped to. The percentage change in VRDN stock occurred in the recent session was 0.38% while the dollar amount for the price change in VRDN stock was $0.06.

VRDN's industry and sector of operation?

The NASDAQ listed VRDN is part of Biotechnology industry that operates in the broader Healthcare sector. Viridian Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VRDN?

Dr. Michael R. Bristow M.D., Ph.D.
Co-Founder, Pres, Chief Executive Officer & Director
Dr. Jonathan Violin M.B.A., Ph.D.
Co-Founder, Chief Executive Officer, Pres & Director
Dr. Marvin H. Caruthers Ph.D.
Co-Founder & Scientific Advisory Board Member
Dr. Rob Henderson Ph.D.
Chief Scientific Officer
Ms. Janielle Newland
Chief Admin. Officer
Dr. Barrett Katz CMO, M.B.A., M.D., MBA
Chief Medical Officer
Mr. Todd James IRC
Senior Vice President of Corporation Affairs & Investor Relations
Ms. Carrie Melvin M.B.A.
Chief Operating Officer
Mr. John A. Jordan
Vice President of Investor Relations & Corporation Communications
Ms. Lara Meisner
Senior Vice President & Gen. Counsel
Mr. Vahe Bedian Ph.D.
Co-Founder & Scientific Advisor
Dr. Barrett Katz M.B.A., M.D., MBA, CMO
Chief Medical Officer
Mr. Kristian Humer M.B.A.
Chief Financial Officer, Chief Bus. Officer, Principal Financial Officer & Principal Accounting Officer
Mr. Scott D. Myers M.B.A.
Pres, Chief Executive Officer & Director

How VRDN did perform over past 52-week?

VRDN's closing price is 39.83% higher than its 52-week low of $11.40 where as its distance from 52-week high of $27.20 is -41.4%.

How many employees does VRDN have?

Number of VRDN employees currently stands at 143.

Link for VRDN official website?

Official Website of VRDN is: https://www.viridiantherapeutics.com

How do I contact VRDN?

VRDN could be contacted at phone 617 272 4600 and can also be accessed through its website. VRDN operates from 221 Crescent Street, Waltham, MA 02453, United States.

How many shares of VRDN are traded daily?

VRDN stock volume for the day was 969.32K shares. The average number of VRDN shares traded daily for last 3 months was 1.33M.

What is the market cap of VRDN currently?

The market value of VRDN currently stands at $1.30B with its latest stock price at $15.94 and 81.49M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	143
Beta	1.09
Sales or Revenue	$314.00K
5Y Sales Change%	-0.998%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology